PT928790E - Derivados de tiazolo - Google Patents

Derivados de tiazolo

Info

Publication number: PT928790E
Authority: PT; Portugal
Prior art keywords: tiazolo; derivatives; tiazolo derivatives
Prior art date: 1998-01-02

Application number

PT98124670T

Other languages

English (en)

Inventor

Leo Alig

Albrecht Edenhofer

Thomas Weller

Kurt Hilpert

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-02

Filing date

1998-12-24

Publication date

2003-07-31

1998-12-24 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2003-07-31 Publication of PT928790E publication Critical patent/PT928790E/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

PT98124670T 1998-01-02 1998-12-24 Derivados de tiazolo PT928790E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP98100006		1998-01-02

Publications (1)

Publication Number	Publication Date
PT928790E true PT928790E (pt)	2003-07-31

Family

ID=8231229

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT98124670T PT928790E (pt)	1998-01-02	1998-12-24	Derivados de tiazolo

Country Status (30)

Country	Link
US (3)	US6100282A (pt)
JP (1)	JP3113237B2 (pt)
KR (1)	KR100312901B1 (pt)
CN (1)	CN1080720C (pt)
AR (1)	AR014949A1 (pt)
AT (1)	ATE233746T1 (pt)
AU (1)	AU720618B2 (pt)
BR (1)	BR9900006A (pt)
CA (1)	CA2257328C (pt)
CO (1)	CO4990934A1 (pt)
DE (1)	DE69811844T2 (pt)
DK (1)	DK0928790T3 (pt)
ES (1)	ES2193471T3 (pt)
HK (1)	HK1020953A1 (pt)
HR (1)	HRP980645A2 (pt)
HU (1)	HUP9803040A3 (pt)
ID (1)	ID21936A (pt)
IL (1)	IL127785A (pt)
MA (1)	MA26591A1 (pt)
NO (1)	NO312067B1 (pt)
NZ (2)	NZ333590A (pt)
PE (1)	PE20000061A1 (pt)
PL (1)	PL330619A1 (pt)
PT (1)	PT928790E (pt)
RU (1)	RU2218337C2 (pt)
SG (1)	SG74686A1 (pt)
TR (1)	TR199802765A2 (pt)
UY (1)	UY25334A1 (pt)
YU (1)	YU61398A (pt)
ZA (1)	ZA9811925B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6911462B2 (en) *	1998-05-22	2005-06-28	Avanir Pharmaceuticals	Benzimidazole compounds for regulating IgE
US6919366B2 (en) *	1998-05-22	2005-07-19	Avanir Pharmaceuticals	Benzimidazole derivatives as modulators of IgE
GB9826174D0 (en) *	1998-11-30	1999-01-20	Celltech Therapeutics Ltd	Chemical compounds
AU5826100A (en)	1999-07-13	2001-01-30	F. Hoffmann-La Roche Ag	Benzazepinones and quinazolines
US6759425B2 (en) *	1999-10-21	2004-07-06	Avanir Pharmaceuticals	Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
MXPA02007099A (es) *	2000-01-19	2004-08-23	Alteon Inc	Compuestos de tiazola, imidazola y oxazola y tratamientos de desordenes asociados con la maduracion de la proteina.
PL364230A1 (en) *	2001-03-12	2004-12-13	Avanir Pharmaceuticals	Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
PE20030968A1 (es) *	2002-02-28	2004-01-12	Novartis Ag	Derivados de 5-feniltiazol como inhibidores de cinasas
TW200304820A (en) *	2002-03-25	2003-10-16	Avanir Pharmaceuticals	Use of benzimidazole analogs in the treatment of cell proliferation
WO2004024655A2 (en)	2002-09-12	2004-03-25	Avanir Pharmaceuticals	Phenyl-indole compounds for modulating ige and inhibiting cellular proliferation
TWI276631B (en) *	2002-09-12	2007-03-21	Avanir Pharmaceuticals	Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
AU2004263190A1 (en) *	2003-08-08	2005-02-17	Avanir Pharmaceuticals	Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases
US7652146B2 (en) *	2004-02-06	2010-01-26	Bristol-Myers Squibb Company	Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors
JP2008513386A (ja) *	2004-09-20	2008-05-01	４エスシーアーゲー	新規な複素環式ＮＦ−κＢ阻害剤
WO2008011191A1 (en) *	2006-07-21	2008-01-24	Replidyne, Inc.	Antibacterial heterocyclic ureas
WO2009015208A1 (en)	2007-07-23	2009-01-29	Replidyne, Inc.	Antibacterial amide and sulfonamide substituted heterocyclic urea compounds
WO2009015193A1 (en) *	2007-07-23	2009-01-29	Replidyne, Inc.	Antibacterial sulfone and sulfoxide substituted heterocyclic urea compounds
TWI504598B (zh) *	2009-03-20	2015-10-21	Onyx Therapeutics Inc	結晶性三肽環氧酮蛋白酶抑制劑
CN102936257B (zh) *	2012-08-30	2016-03-30	齐鲁工业大学	一类含银的噻唑西弗碱配合物的结构、制备和用途
EP3645531A1 (en)	2017-06-29	2020-05-06	Bayer Aktiengesellschaft	Thiazole compounds useful as prmt5 inhibitors

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2009155B (en) *	1977-11-07	1982-07-21	Leo Pharm Prod Ltd	Chemical compounds
FR2581063B1 (fr)	1985-04-30	1987-07-17	Chauvin Blache Lab	Amino-2 thiazoles n-substitues, leur procede de preparation et leur application en therapeutique
JPS62123180A (ja) *	1985-11-21	1987-06-04	Otsuka Pharmaceut Factory Inc	ｐ−アミノフエノ−ル誘導体
US5000775A (en) *	1985-12-31	1991-03-19	Monsanto Company	2-amino-4,5-disubstituted-oxazole/thiazole compounds as herbicide antidotes
JPS6348873A (ja) *	1986-08-19	1988-03-01	Toshiba Corp	ガスレ−ザ発振装置
CA2037153A1 (en) *	1990-03-09	1991-09-10	Leo Alig	Acetic acid derivatives
US5273982A (en) *	1990-03-09	1993-12-28	Hoffmann-La Roche Inc.	Acetic acid derivatives
FI922867A (fi) *	1991-06-21	1992-12-22	Tanabe Seiyaku Co	Dikarbonsyraderivat och foerfarande foer framstaellning av dem
AU646966B2 (en) *	1991-08-23	1994-03-10	Takeda Chemical Industries Ltd.	2-piperazinone compounds, their production and use
GB9125970D0 (en) *	1991-12-06	1992-02-05	Fujisawa Pharmaceutical Co	New compounds
US5514643A (en) *	1993-08-16	1996-05-07	Lucky Ltd.	2-aminothiazolecarboxamide derivatives, processes for preparing the same and use thereof for controlling phytopathogenic organisms
US6306840B1 (en) *	1995-01-23	2001-10-23	Biogen, Inc.	Cell adhesion inhibitors
JPH08337579A (ja) *	1995-06-14	1996-12-24	Fujisawa Pharmaceut Co Ltd	グアニジノチアゾ−ルおよびその抗潰瘍剤、ｈ２−受容体拮抗剤および抗菌剤としての用途
JPH09295974A (ja) *	1995-09-11	1997-11-18	Nippon Nohyaku Co Ltd	アゾール誘導体、その用途及びその製造方法並びにその使用方法
AU679887B2 (en) *	1995-09-11	1997-07-10	Nihon Nohyaku Co., Ltd.	Azole derivatives, their use, production and usage
EP0871619B1 (en) *	1995-12-29	2002-11-06	Boehringer Ingelheim Pharmaceuticals Inc.	Phenyl thiazole derivatives with anti herpes virus properties
MA26487A1 (fr) *	1997-04-29	2004-12-20	Smithkline Beecham Corp	Heterocyclecetohydrazides inhibiteurs de proteases, procede pour leur preparation et compositions pharmaceutiques les contenant .

1998
- 1998-12-22 US US09/218,567 patent/US6100282A/en not_active Expired - Fee Related
- 1998-12-24 NZ NZ333590A patent/NZ333590A/xx unknown
- 1998-12-24 PT PT98124670T patent/PT928790E/pt unknown
- 1998-12-24 NZ NZ333591A patent/NZ333591A/xx unknown
- 1998-12-24 DK DK98124670T patent/DK0928790T3/da active
- 1998-12-24 ES ES98124670T patent/ES2193471T3/es not_active Expired - Lifetime
- 1998-12-24 AT AT98124670T patent/ATE233746T1/de not_active IP Right Cessation
- 1998-12-24 DE DE69811844T patent/DE69811844T2/de not_active Expired - Fee Related
- 1998-12-28 NO NO19986159A patent/NO312067B1/no unknown
- 1998-12-29 PE PE1998001293A patent/PE20000061A1/es not_active Application Discontinuation
- 1998-12-29 AR ARP980106723A patent/AR014949A1/es not_active Application Discontinuation
- 1998-12-29 IL IL12778598A patent/IL127785A/en not_active IP Right Cessation
- 1998-12-29 ZA ZA9811925A patent/ZA9811925B/xx unknown
- 1998-12-29 HR HR98100006.0A patent/HRP980645A2/hr not_active Application Discontinuation
- 1998-12-30 PL PL98330619A patent/PL330619A1/xx not_active Application Discontinuation
- 1998-12-30 HU HU9803040A patent/HUP9803040A3/hu unknown
- 1998-12-30 TR TR1998/02765A patent/TR199802765A2/xx unknown
- 1998-12-30 CO CO98077476A patent/CO4990934A1/es unknown
- 1998-12-30 AU AU96144/98A patent/AU720618B2/en not_active Ceased
- 1998-12-30 SG SG1998005978A patent/SG74686A1/en unknown
- 1998-12-30 MA MA25411A patent/MA26591A1/fr unknown
- 1998-12-30 CA CA002257328A patent/CA2257328C/en not_active Expired - Fee Related
- 1998-12-30 YU YU61398A patent/YU61398A/sh unknown
- 1998-12-31 CN CN98125982A patent/CN1080720C/zh not_active Expired - Fee Related
- 1998-12-31 UY UY25334A patent/UY25334A1/es not_active IP Right Cessation
- 1998-12-31 KR KR1019980063364A patent/KR100312901B1/ko not_active IP Right Cessation
1999
- 1999-01-04 JP JP11000010A patent/JP3113237B2/ja not_active Expired - Fee Related
- 1999-01-04 ID IDP990001D patent/ID21936A/id unknown
- 1999-01-04 BR BR9900006-7A patent/BR9900006A/pt not_active Application Discontinuation
- 1999-01-05 RU RU99100277/04A patent/RU2218337C2/ru not_active IP Right Cessation
- 1999-12-28 HK HK99106136A patent/HK1020953A1/xx not_active IP Right Cessation
2000
- 2000-03-15 US US09/526,033 patent/US6320054B1/en not_active Expired - Fee Related
2001
- 2001-06-11 US US09/878,704 patent/US6344562B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
IL127785A0 (en)	1999-10-28
PE20000061A1 (es)	2000-02-09
CA2257328C (en)	2006-05-09
CN1080720C (zh)	2002-03-13
US6344562B1 (en)	2002-02-05
ID21936A (id)	1999-08-12
US6320054B1 (en)	2001-11-20
NZ333590A (en)	2000-05-26
ES2193471T3 (es)	2003-11-01
DK0928790T3 (da)	2003-06-30
CN1224718A (zh)	1999-08-04
SG74686A1 (en)	2000-08-22
CA2257328A1 (en)	1999-07-02
KR100312901B1 (ko)	2002-01-15
RU2218337C2 (ru)	2003-12-10
US20020010316A1 (en)	2002-01-24
JP3113237B2 (ja)	2000-11-27
AU720618B2 (en)	2000-06-08
HUP9803040A3 (en)	2001-04-28
HUP9803040A2 (hu)	2000-04-28
BR9900006A (pt)	2000-04-11
CO4990934A1 (es)	2000-12-26
ATE233746T1 (de)	2003-03-15
TR199802765A3 (tr)	1999-07-21
HK1020953A1 (en)	2000-05-26
MA26591A1 (fr)	2004-12-20
NO312067B1 (no)	2002-03-11
NO986159L (no)	1999-07-05
UY25334A1 (es)	2001-01-31
US6100282A (en)	2000-08-08
ZA9811925B (en)	2000-06-29
YU61398A (sh)	2001-12-26
PL330619A1 (en)	1999-07-05
AR014949A1 (es)	2001-04-11
DE69811844T2 (de)	2003-12-04
HRP980645A2 (en)	1999-10-31
IL127785A (en)	2004-09-27
KR19990066925A (ko)	1999-08-16
HU9803040D0 (en)	1999-02-01
DE69811844D1 (de)	2003-04-10
TR199802765A2 (xx)	1999-07-21
JP2000053664A (ja)	2000-02-22
AU9614498A (en)	1999-07-22
NZ333591A (en)	2000-05-26
NO986159D0 (no)	1998-12-28

Publication	Publication Date	Title
PT930302E (pt)	2003-07-31	Derivados de benzo-sulfona
NO20010193D0 (no)	2001-01-12	Tiobenzimidazol-derivater
PT1005446E (pt)	2004-06-30	Derivados de n-aroilfenilalanina
PT1104422E (pt)	2004-06-30	Derivados de fenilxantina
NO20010514D0 (no)	2001-01-30	Aminometylkarboksylsyre-derivater
DE69934788D1 (de)	2007-02-22	Biozide benzylbiphenylderivative
PT915088E (pt)	2003-01-31	Derivados de d-prolina
DE69925611D1 (de)	2005-07-07	Stopfbüchsenvorrichtung
FI980532A0 (fi)	1998-03-09	Talkodning
DE69933073D1 (de)	2006-10-19	Informationsaufzeichnungsträgercassette
PT928790E (pt)	2003-07-31	Derivados de tiazolo
ID24221A (id)	2000-07-13	Tempat patrum
PT1027362E (pt)	2005-08-31	Derivados de cetolidos 2-halogeno-6-o-substituidos
PT1003719E (pt)	2002-10-31	Derivados microbicidas de n-sulfonil-glicinalquiniloxifenemetilamida
PT1154988E (pt)	2004-12-31	Derivados de mevinolina
PT1056716E (pt)	2003-04-30	Derivados de ciclo-hexanodiolo
PT1187815E (pt)	2006-06-30	Derivados de 4-fenil-pirimidina
DK1115716T3 (da)	2003-02-24	2-phenylpyran-4-on-derivater
ATE233253T1 (de)	2003-03-15	Chromanderivate
DK1134219T3 (da)	2005-10-17	Cucloalkylsubstituerede aminomethylpyrrolidinderivater
FI980251A0 (fi)	1998-02-04	Breddstraeckvals
DK1060183T3 (da)	2003-08-11	5-deoxycytidinderivater
PT1088818E (pt)	2005-03-31	Derivados de quinolin-4-ilo
PT1194401E (pt)	2004-02-27	Derivados de diacil-hidrazina
PT1123283E (pt)	2004-09-30	Derivados de tiazole